Young patients who suffer patellar dislocations at higher risk of recurring injuries, study finds

Young patients who suffer patellar dislocations are at a higher risk of recurring dislocations, especially long-term after their initial injury, according to research presented today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Toronto, Ontario, Canada. Researchers received the Herodicus Award, presented to the best resident paper featured at the meeting, and determined by the Herodicus Society.

"Our research showed that within the study group, 104 patients had ipsilateral recurrent patellar dislocation, with over 20% of cases occurring in the first two years following the initial injury," noted Thomas L. Sanders, MD, corresponding author from the Mayo Clinic. "By 15 and 20 years, this number had reached 54% of patients -- a concerning rate of recurrence."

The study included 232 skeletally immature patients, defined as such if their proximal tibia and distal femoral physes were open at the time of dislocation. Those selected experienced a first-time lateral patellar dislocation between 1990 and 2010. Subjects were followed for a mean of 12.1 years to determine rates of subsequent dislocations, or clinically significant patellofemoral arthritis.

"Despite high numbers of recurrence, our research showed that these young patients did not develop significant patellofemoral arthritis," commented Sanders. "We hope to use our research to help educate both physicians and parents on the risks young athletes face after these injuries in their early years, and hopefully take steps to prevent them."

The study adds to previous studies, which typically show 40% of adolescent patients go on to experience a recurring patellar dislocation.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mapping human biology: Human Cell Atlas leads a new era in precision medicine